High Rates of Prostate-specific Antigen Testing in Men with Evidence of Benign Prostatic Hyperplasia

Physician and patient education are needed to promote more rational and selective use of PSA testing among men least likely to benefit from early cancer detection and among men most likely to have a false-positive PSA result (men with benign prostatic hyperplasia).

Abstract

These US health professionals reported preferential use of PSA testing among men least likely to benefit from early cancer detection (older men) and among men most likely to have a false-positive PSA result (men with benign prostatic hyperplasia). Physician and patient education are needed to promote more rational and selective use of this screening test.